Dopamine (DA) receptor systems are related to the mechanism of action of antipsychotic drugs, and to their sometimes serious neurological side effects, such as tardive dyskinesia. The proposal continues our long-term objectives of elucidating the basic molecular and neuropharmacological properties of forebrain DA systems, and discovering relationships between these properties and the psychopharmacological effects of drugs used to treat the most severely ill psychiatric patients.
The specific aims of this project focus on elaborating and clarifying subtle but extremely important differences that have been discovered in various DA systems in mammalian brain. Specifically, we propose to elucidate the neuropharmacological differences between DA systems located in the nigrostriatal, mesolimbic, and mesocortical regions. We will also continue to explore genetic differences in DA systems in mouse strains, and undertake an in depth investigation of changes that occur in regional DA systems during development. These studies are important in advancing our understanding of the etiology and treatment of psychotic disorders such as schizophrenia, and neuropsychiatric disorders such as Parkinson's and Huntington's diseases and Tourette's syndrome, as well as the spontaneous and drug-induced dyskinesias. These studies will exploit several new techniques and discoveries. Of particular importance has been the design and synthesis of a novel class of chemical agents, the optical S(+)-isomers of apomorphine, that appear to interact selectively with limbic DA systems, and promise to provide a potential breakthrough in the development of safer antipsychotic agents. Newer related agents, including radioactive tracers, will be synthesized as chemical probes to determine the basis for this selectivity, and to further characterize DA receptors. They will be studied for effects on regional dopamine binding and metabolism, as well as actions on regional energy utilization using chromatographic and autoradiographic techniques with brain homogenates and slices. Developmental studies will concentrate on the marked changes in DA metabolism, turnover, and autoreceptor function that occur with maturation and aging, and will provide important information on the long-term effects of these agents on neural systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH034006-09
Application #
3375481
Study Section
(BPNA)
Project Start
1980-04-01
Project End
1989-06-30
Budget Start
1988-04-01
Budget End
1989-06-30
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Mc Lean Hospital (Belmont, MA)
Department
Type
DUNS #
City
Belmont
State
MA
Country
United States
Zip Code
02478
Bois, Frederic; Baldwin, Ronald M; Amici, Louis et al. (2008) Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer. Nucl Med Biol 35:53-9
Bois, Frederic; Baldwin, Ronald M; Kula, Nora S et al. (2006) Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(4'-p-substituted phenyl)-piperidine analogs of cocaine. Bioorg Med Chem Lett 16:5222-5
Davids, Eugen; Zhang, Kehong; Tarazi, Frank I et al. (2003) Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev 42:1-21
Frazier, Jean A; Cohen, Louise Glassner; Jacobsen, Leslie et al. (2003) Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia. J Clin Psychopharmacol 23:87-91
Tarazi, Frank I; Zhang, Kehong; Baldessarini, Ross J (2002) Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain. Nitric Oxide 7:297-300
Zhang, Kehong; Tarazi, Frank I; Davids, Eugen et al. (2002) Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology 26:625-33
Davids, Eugen; Zhang, Kehong; Tarazi, Frank I et al. (2002) Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Psychopharmacology (Berl) 160:92-8
Zhu, Meng-Yang; Kim, Chun-Hyung; Hwang, Dong-Youn et al. (2002) Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue. J Neurochem 82:146-53
Zhang, Kehong; Davids, Eugen; Tarazi, Frank I et al. (2002) Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Brain Res Dev Brain Res 137:135-8
Fu, Xing; Tan, Ping-Zhong; Kula, Nora S et al. (2002) Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging. J Med Chem 45:2319-24

Showing the most recent 10 out of 98 publications